Showing results (101-110 of 221) with videos related to
Sort By:
Pageof 23
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2006
A novel pathway of cell growth regulation mediated by a PLA2alpha-derived phosphoinositide metaboliteStefania Mariggiò, Jordi Sebastià, Beatrice Maria Filippi, et al.The Journal of Clinical Endocrinology and Metabolism|March 26, 2013
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancerValentina De Falco, Preziosa Buonocore, Magesh Muthu, et al.Healthcare (Basel, Switzerland)|May 28, 2022
Oxidative Stress Status in Post Stroke Patients: Sex DifferencesMariacristina Siotto, Marco Germanotta, Massimo Santoro, et al.The Journal of Clinical Endocrinology and Metabolism|November 20, 2013
The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutationsChan Kwon Jung, Mark P Little, Jay H Lubin, et al.The Journal of Biological Chemistry|August 25, 2006
Structure and chemical inhibition of the RET tyrosine kinase domainPhillip P Knowles, Judith Murray-Rust, Svend Kjaer, et al.Scientific Reports|May 23, 2025
Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STINGGiorgia Federico, Angelo Rosario Carotenuto, Arsenio Cutolo, et al.Journal of Medicinal Chemistry|September 7, 2018
Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical ApplicationWei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, et al.Molecular and Cellular Biology|September 21, 2002
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathwayGiuliana Pelicci, Flavia Troglio, Alessandra Bodini, et al.Neuropathology and Applied Neurobiology|July 30, 2013
Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubesMassimo Santoro, Roberto Piacentini, Marcella Masciullo, et al.The Journal of Clinical Endocrinology and Metabolism|November 3, 2009
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.Pageof 23